Case-Based Roundtables on TargetedOnc.com are collaborative, small-group discussions about case-based clinical profiles and engaging peer-dialogue led by an expert physician. These resources offer practicing oncologists and hematologists insight on relevant data, treatment strategies, and varying professional opinions.
LATEST GI CANCERS CONTENT
Factors Affecting First-Line ICI Choice in HER2-Negative Gastric Cancer
Navigating Treatment Selection for Advanced NETs
Oncologists Weigh Real-World Nuances in First-Line Gastric Cancer
Balancing Efficacy and Tumor Control in Pancreatic NET Therapy Sequencing
Advanced Extrapancreatic NETs: Sequencing Treatment Strategies
Why Biomarker Testing Can’t Be an Afterthought in Upper GI Cancer
Interpreting Key Trial Data in the Era of IO in Advanced HCC
Checkpoint Inhibitors in Advanced Upper GI Cancers After 2024 FDA Shift
CASE-BASED ROUNDTABLES
Advertisement
Advertisement